Convulsion following intrathecal cephaloridine.
Following therapeutic intrathecal administration of cephaloridine to an 11-day-old premature infant with suspected meningitis, a generalized tonic convulsion was observed. Symptoms continued to subside over the next six hours, followed by postictal sleep. That convulsion and other symptoms were due to cephaloridine was confirmed when the second intrathecal administration produced the same symptom. Because of its possible damaging effect on CNS, it is strongly suggested that cephaloridine should not be administered directly into the cerebrospinal fluid space.
D002509:Cephaloridine / Q000009:adverse effects*; D004569:Electroencephalography; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007278:Injections, Spinal / Q000009:adverse effects; D008297:Male; D012640:Seizures / Q000139:chemically induced*
D002509:Cephaloridine